Age, gender, subtype may influence recurrence of AMD after anti-VEGF treatment

Recurrence of neovascular age-related macular degeneration after anti-VEGF treatment may be associated with age and gender, and occur sooner in patients with polypoidal choroidal vasculopathy, according to a study.The retrospective cohort study evaluated 343 Asian eyes with subfoveal neovascular age-related macular degeneration (AMD) treated with three monthly loading injections of ranibizumab to investigate the predictive factors of recurrence after more than 1 year.